SCHEMBL16004337

SCHEMBL16004337

COc1ccc(Cl)cc1S(=O)(=O)N1CCOc2ccc(COCc3ccccc3)cc2C1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 3/20 0.47
POLB P06746 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HPGD P15428 1/20 0.47
RAB9A P51151 1/20 0.47
CPT1A P50416 5/20 0.47
TDP1 Q9NUW8 1/20 0.46
CPT1B Q92523 4/20 0.46
ALOX12 P18054 1/20 0.46
GAA P10253 1/20 0.45
ATM Q13315 1/20 0.44
TSHR P16473 2/20 0.44
PKM P14618 1/20 0.43
CPT2 P23786 2/20 0.43
RXFP1 Q9HBX9 1/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16004261 0.92 LMNA (0.48) LMNASMN1; SMN2ALDH1A1POLBKDM4E
SCHEMBL16004260 0.82 CCR3 (0.50) LMNAALDH1A1KDM4ETSHRMEN1
SCHEMBL16004256 0.82 L3MBTL1 (0.42) LMNASMN1; SMN2ALDH1A1POLBRAB9A
SCHEMBL16004328 0.79 ALDH1A1 (0.43) LMNASMN1; SMN2ALDH1A1GAATSHR
SCHEMBL16004325 0.79 RORC (0.44) LMNASMN1; SMN2ALDH1A1RAB9APKM
SCHEMBL16004226 0.78 PKM (0.46) LMNASMN1; SMN2ALDH1A1POLBKDM4E
SCHEMBL16004100 0.78 EBP (0.44) ALDH1A1MEN1KMT2A
SCHEMBL16004010 0.78 PKM (0.55) LMNASMN1; SMN2ALDH1A1KDM4ERAB9A
SCHEMBL16004016 0.77 PKM (0.43) LMNASMN1; SMN2ALDH1A1RAB9AGAA
SCHEMBL16004227 0.77 PKM (0.43) LMNASMN1; SMN2ALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014133414-A2 HETEROCYCLIC TGR5 BILE ACID RECEPTOR AGONISTS, PHARMACEUTICAL COMPOSITION, METHODS FOR THE PRODUCTION AND USE THEREOF АЛЛА ХЕМ ЛЛС (US) 2014-09-04 WO disclosed